Olema Pharmaceuticals (OLMA) Accounts Payables (2020 - 2026)
Olema Pharmaceuticals (OLMA) posted quarterly Accounts Payables of $3.7 million for Q1 2026, up 2362.91% year-over-year from $151000.0 in Q1 2025, and down 59.81% quarter-over-quarter from $9.3 million in Q4 2025.
Olema Pharmaceuticals (OLMA) Accounts Payables (2020 - 2026) Analysis & Trends
Olema Pharmaceuticals (OLMA) has reported Accounts Payables for 7 consecutive years, with $3.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables rose 2362.91% year-over-year to $3.7 million; the TTM figure through Mar 2026 stood at $3.7 million (up 2362.91% YoY), while the FY2025 annual figure was $9.3 million, up 107.47% from the prior year.
- Accounts Payables slipped to $3.7 million in Q1 2026 per OLMA's latest filing, from $9.3 million in the prior quarter.
- Across five years, Accounts Payables topped out at $9.3 million in Q4 2025 and bottomed at $14000.0 in Q3 2022.
- Historically, Accounts Payables has averaged $2.6 million across 5 years, with a median of $2.2 million in 2023.
- Annual changes were most pronounced in 2023 — Accounts Payables soared 15664.29% — and 2025, when it tumbled 98.03%.
- Olema Pharmaceuticals' Accounts Payables stood at $374000.0 in 2022, then surged by 621.39% to $2.7 million in 2023, then surged by 65.31% to $4.5 million in 2024, then jumped by 107.47% to $9.3 million in 2025, then plunged by 59.81% to $3.7 million in 2026.
- Business Quant data shows OLMA's Accounts Payables at $3.7 million in Q1 2026, $9.3 million in Q4 2025, and $3.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Olema Pharmaceuticals | 930.10 Mn | 930.10 Mn | - | 1.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.67 Mn |
| Mar 31, 2026 | 3.72 Mn |
| Dec 31, 2025 | 9.25 Mn |
| Sep 30, 2025 | 3.47 Mn |
| Jun 30, 2025 | 934,000.00 |
| Mar 31, 2025 | 151,000.00 |
| Dec 31, 2024 | 4.46 Mn |
| Sep 30, 2024 | 2.69 Mn |
| Jun 30, 2024 | 4.35 Mn |
| Mar 31, 2024 | 7.66 Mn |
| Dec 31, 2023 | 2.70 Mn |
| Sep 30, 2023 | 2.21 Mn |
| Jun 30, 2023 | 1.63 Mn |
| Mar 31, 2023 | 681,000.00 |
| Dec 31, 2022 | 374,000.00 |
| Sep 30, 2022 | 14,000.00 |
| Jun 30, 2022 | 120,000.00 |
| Mar 31, 2022 | 268,000.00 |
| Dec 31, 2021 | 23,000.00 |
| Sep 30, 2021 | 306,000.00 |